Subscribe To
LBPH / Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why
LBPH News
By Zacks Investment Research
May 1, 2023
Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable
Longboard Pharmaceuticals, Inc. (LBPH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundament more_horizontal
By Zacks Investment Research
April 14, 2023
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why
Longboard Pharmaceuticals, Inc. (LBPH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a more_horizontal
By Zacks Investment Research
April 7, 2023
Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect?
The mean of analysts' price targets for Longboard Pharmaceuticals, Inc. (LBPH) points to a 208.2% upside in the stock. While this highly sought-after more_horizontal
By Seeking Alpha
March 2, 2023
Longboard Pharmaceuticals, Inc. (LBPH) Q4 2022 Results - Earnings Call Transcript
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH ) Q4 2022 Results Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Brandi Roberts - more_horizontal
By Business Wire
February 23, 2023
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023
SAN DIEGO--(BUSINESS WIRE)---- $LBPH #Epilepsy--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on more_horizontal
By Seeking Alpha
November 23, 2022
Longboard Pharmaceuticals: Arena Team's Next Act Is Flying Under The Radar
Shares have fallen by nearly 70% since IPO. Leadership including President & CEO hails from Arena Pharmaceuticals (bought out by Pfizer for $6.7B last more_horizontal
By GlobeNewsWire
August 3, 2022
Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on dev more_horizontal